InsidersTradesSigma
Follow the LEMAITRE VASCULAR, INC. stock price and the full management transaction log of the company, a listed equity based in United States. Shares are listed on the US market, under the supervision of SEC (Form 4). Market capitalisation: €2.3bn. The latest transaction was disclosed on 29 July 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: BRIDGET A ROSS. Every trade is free.
Analysts rate LEMAITRE VASCULAR, INC. Strong Buy (bullish), based on 12 analysts. Average price target: US$62.05.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
LEMAITRE VASCULAR, INC. is a company focused on the development and commercialization of medical devices for the treatment of vascular diseases. It is listed on NASDAQ under the ticker LMAT.